Back to search
Central Precocious Puberty (CPP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Precocious Puberty (CPP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Precocious Puberty (CPP) trials you may qualify forObservational, retrosopective, single-centre, non-profit study focused on the frequency of Central Precocious Puberty idiopathic, or associated to Neurodevelopm…
This study is a multicenter, open-label, single-group, and phase 4 study to evaluate the efficacy and safety of 45 mg of leuprolide acetate in CPP. Screening t…
Central precocious puberty (CPP) is characterized by the early activation of the hypothalamic-pituitary-gonadal axis in girls and may be difficult to distinguis…
The main purpose is to describe how many children were treated during 24 months or less because of CPP and how treatment worked for them. There are no particip…
The main aim is to see how leuprolide works to treat central precocious puberty in children. Participants will receive an injection of leuprorelin acetate depot…